Laila Gharzai MD LLM

Great session at CHEST 2025 to discuss changes and implementation challenges of TNM-9 Staging of Lung Cancer. @accpchest @AAB_IP @wabipconnect @DukePulmFellows @DukeSurgery @DukeCancer @DukeCancerNTWK @DukePACC

Dr @LGharzai on medical debt in pts receiving #radiation. #ASTRO25 Most had OOP expenses (61.1%, n=8701), mean $825.80 (SD 2114.5), median $25 (IQR 0-685.90). Few had bad debt (2.7%, n=397), with a mean of $1109.90 outstanding (SD 4215.5) after a mean of 9.3 mo (SD 3.9).

Throat cancer survivor Paula Ruska and her doctor, @LGharzai , mark National #cancersurvivormonth by sharing their experience and discussing the need for continued care after treatment. news.northwestern.edu/stories/2025/0…

Unmet needs such as transport and finances forcing cancer patients to miss imaging appointments. @UCIMedSchool @RadiologyACR @JACRJournal @LGharzai ow.ly/cBkV50VyVRT

Our team demonstrates the first ever validation of COST Item 12 as a single item screening measure for financial toxicity—can be used as a brief, single item screener with excellent sensitivity for detecting patients at high risk of financial distress. ascopubs.org/doi/10.1200/OP…

Asking patients for guidance based on their lived experience is key, says Lurie Cancer Center's Laila Gharzai, MD, (@LGharzai), co-author of a recent study about #financialtoxicity screening preferences in @JCOOP_ASCO. "They've actually been through it."

@ThePinkFund @GelarehSadigh @reshmajagsi

Excited to share our newest fin tox work—we ask cancer patients for guidance on how best to screen for financial toxicity. Patients tell us that they want screening to be early, often, and initiated by their providers. Important implications for policy. ascopubs.org/doi/10.1200/OP…

Short summary PRO measures offer the opportunity to frequently screen patients undergoing treatment without unduly burdening patients. We show that FACT GP5, assessing side effect bother, is a promising summary measure for head/neck cancer patients. link.springer.com/article/10.100…

@rajatthawani @OncLive @UChicagoHemOnc @NorthwesternMed @your_hemoncdoc @JPatelMD @DivyaGuptaMD @DrRoyHerbstYale @DrEdKim @JSabari ♥️🥊💜

@OncLive Face-Off between @UChicagoHemOnc and @NorthwesternMed ! Debated lung cancer, while discussing our rivalry! Purple vs Maroon! @your_hemoncdoc @JPatelMD @LGharzai @DivyaGuptaMD With judges @DrRoyHerbstYale @DrEdKim @JSabari

Poster #282 right now in the exhibit hall!

Check out our paper on screening for financial toxicity in patients with cancer! #LeilaMady @LGharzai @hopkins_ent Preventing and addressing FT begins with detecting it. We discuss the available tools, best practices, and common risk factors. jacr.org/article/S1546-…

@theabzlab @lesagniksarkar @NorthwesternU @LurieCancer @troyteo @AmulyaYala @JamesRandallMD1 Excellent—looking forward to seeing more and learning how to apply this work prospectively!

Congrats @lesagniksarkar and Zhuoyang Zou for your excellent presentations @ #CoDEx 2024! Two new DNN models (toxicity prediction and lung cancer target segmentation) are coming to an information system near you.

@DrMLChua @JJCaudell Absolutely—our next steps include updating this with newer data!

@JJCaudell @LGharzai Interesting LRPFS still fit the bill, but I presume that's largely due to the early trials investigating C225+RT. Probably needs updating in due course with the newer studies.

Surrogate endpoints for HPV+ HN cancer; an analysis of 5 NRG Oncology studies. LRPFS, DMFS, and PFS seem to fit the bill. authors.elsevier.com/c/1ifvZ5EIIgPd… @LGharzai

Excited to share our work showing the first validation of surrogate endpoints in HPV+ oropharyngeal cancer! We show that LRPFS, DMFS, and PFS correlate with 5yr OS. Important for trial design in this evolving dx space @MierzwaMichelle @StatMatt9 @NRGonc sciencedirect.com/science/articl…

The FACT-HN-RAD offers a means to serially monitor patients with radiation therapy-related adverse effects and recovery over time in both the clinical and research settings. ja.ma/3sfS84e @lgharzai @mierzwamichelle

LCRF Together Chicago is June 6 at The Ivy Room! Join our gathering & educational event with Drs. Nisha Mohindra, Jessica Donington, Laila A. Gharzai, & Melanie M. Smith; and moderator Ivy Elkins. Refreshments 5:30 PM; panel 6:30 PM. RSVP: LCRF.org/togetherchicago. #LungCancer

Original Article: “Meta-Analysis of Candidate Surrogate End Points in Advanced Prostate Cancer,” by @LGharzai et al. eviden.cc/3zeUxg1 #OncoAlert #MedTwitter